In addition, the Company has begun development of a formulation for rekvry™ – an alcohol misuse treatment for emergency and hospital settings. The Company believes that rekvry™ fulfills an unmet need ...

Nasdaq-listed shares of Quantum BioPharma (QNTM) surged 15% on Wednesday after the companysaid its licensee, Celly Nutrition ...

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company, announced the closing of its final tranche in a debenture unit offering, raising a tot ...

The company shed its FSD Pharma identity last year as it positions its alcohol metabolism and multiple sclerosis treatments ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...

New Ultra-Portable unbuzzd™ Single-Use Powder Sticks in Convenient 8-Pack Display Boxes Now Available for US Retailers TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ ...

09:42 EST QNTM Stock trading halted, volatility trading pause Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and ...

Quantum BioPharma (QNTM) announces the appointment of Terry Lynch to its board of directors. Lynch will be replacing Dr. Sanjiv Chopra, who has ...

(RTTNews) - Quantum BioPharma Ltd. (QNTM) announced the completion of its Phase 1 clinical trial for Lucid-21-302 or Lucid-MS, an experimental drug designed to treat multiple sclerosis. The trial ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...